Cargando…

A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma

BACKGROUND: Liquid biopsies do not reflect the complete mutation profile of the tumor but have the potential to identify actionable mutations when tumor biopsies are not available as well as variants with low allele frequency. Most retrospective studies conducted in small cohorts of pediatric cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cimmino, Flora, Lasorsa, Vito Alessandro, Vetrella, Simona, Iolascon, Achille, Capasso, Mario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769379/ https://www.ncbi.nlm.nih.gov/pubmed/33381456 http://dx.doi.org/10.3389/fonc.2020.596191

Ejemplares similares

An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
por: Formicola, Daniela, et al.
Publicado: (2016)

Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2020)

19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
por: Lasorsa, Vito Alessandro, et al.
Publicado: (2020)

Kinome multigenic panel identified novel druggable EPHB4‐V871I somatic variant in high‐risk neuroblastoma
por: Andolfo, Immacolata, et al.
Publicado: (2020)

FGFR1 is a potential therapeutic target in neuroblastoma
por: Cimmino, Flora, et al.
Publicado: (2022)

Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
por: Avitabile, Marianna, et al.
Publicado: (2020)

A comprehensive characterization of rare mitochondrial DNA variants in neuroblastoma
por: Calabrese, Francesco Maria, et al.
Publicado: (2016)

CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
por: Formicola, Daniela, et al.
Publicado: (2022)

Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progression
por: Lasorsa, Vito Alessandro, et al.
Publicado: (2016)

Exploring Shared Susceptibility between Two Neural Crest Cells Originating Conditions: Neuroblastoma and Congenital Heart Disease
por: Testori, Alessandro, et al.
Publicado: (2019)

Genetic Analysis of the Coronavirus SARS-CoV-2 Host Protease TMPRSS2 in Different Populations
por: Russo, Roberta, et al.
Publicado: (2020)

Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells
por: Cimmino, Flora, et al.
Publicado: (2015)

Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways
por: Avitabile, Marianna, et al.
Publicado: (2022)

HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia
por: Cimmino, Flora, et al.
Publicado: (2019)

Impact of Interleukin-6 –174 G>C Gene Promoter Polymorphism on Neuroblastoma
por: Totaro, Francesca, et al.
Publicado: (2013)

Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma
por: Bonfiglio, Ferdinando, et al.
Publicado: (2022)

Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA
por: Diefenbach, Russell J., et al.
Publicado: (2022)

Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
por: Trinidad, Eva María, et al.
Publicado: (2023)

Genetic Predisposition to Solid Pediatric Cancers
por: Capasso, Mario, et al.
Publicado: (2020)

Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells
por: Jemaà, Mohamed, et al.
Publicado: (2020)

Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Sebastião, Mariana M., et al.
Publicado: (2020)

Discovery of epi-Enprioline as a Novel Drug for the Treatment of Vincristine Resistant Neuroblastoma
por: Sime, Wondossen, et al.
Publicado: (2020)

BAP1 induces cell death via interaction with 14-3-3 in neuroblastoma
por: Sime, Wondossen, et al.
Publicado: (2018)

Immunosuppressive Microenvironment in Neuroblastoma
por: Pistoia, Vito, et al.
Publicado: (2013)

Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
por: Southgate, Harriet E. D., et al.
Publicado: (2020)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Direct comparison of circulating tumor DNA sequencing assays with targeted large gene panels
por: Yu, Lizhi, et al.
Publicado: (2022)

Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML
por: Ruan, Min, et al.
Publicado: (2021)

Detectability of Plasma-Derived Circulating Tumor DNA Panel in Patients Undergoing Primary Treatment for Uveal Melanoma
por: Francis, Jasmine H., et al.
Publicado: (2022)

CD55 is a HIF-2α marker with anti-adhesive and pro-invading properties in neuroblastoma
por: Cimmino, F, et al.
Publicado: (2016)

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
por: Knapp, Brendan, et al.
Publicado: (2022)

Pro-metastatic and mesenchymal gene expression signatures characterize circulating tumor cells of neuroblastoma patients with bone marrow metastases and relapse
por: Loh, Amos H. P., et al.
Publicado: (2022)

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

The Use of Circulating Tumor DNA for Prognosis of Gastrointestinal Cancers
por: Saluja, Hariti, et al.
Publicado: (2018)

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
por: Mody, Kabir, et al.
Publicado: (2018)

Targeted parallel DNA sequencing detects circulating tumor‐associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma
por: Riehl, Lara, et al.
Publicado: (2022)

Plasma Circulating Tumor DNA Sequencing Predicts Minimal Residual Disease in Resectable Esophageal Squamous Cell Carcinoma
por: Liu, Tao, et al.
Publicado: (2021)

Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma
por: Wu, Xiao-Bo, et al.
Publicado: (2022)

Nanocarrier-Mediated Targeting of Tumor and Tumor Vascular Cells Improves Uptake and Penetration of Drugs into Neuroblastoma
por: Pastorino, Fabio, et al.
Publicado: (2013)

Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing
por: Fabrizio, Federico Pio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sais8snr8l7etv1hbks0b15l3b